AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLBK
  4. [Form 4] Columbia Financial, Inc. Insider Trading Activity

[Form 4] Columbia Financial, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK) reported transactions dated 09/05/2025 on a Form 4. The filing shows a non-derivative acquisition on 09/05/2025 of 42.5356 shares at $15.01. The table lists various categories of beneficial ownership following the reported transactions, including 7,807.5331 shares held indirectly and other plan-based and award-based indirect holdings (for example, 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Derivative holdings show stock options totaling 229,425 options across four option grants with exercise prices of $15.60, $15.94, $16.49, and $16.23, with expiration dates through 2035.

John Klimowich, SEVP e Chief Risk Officer di Columbia Financial, Inc. (CLBK) ha dichiarato operazioni datate 05/09/2025 in un Modulo 4. La comunicazione indica un acquisto non derivato, effettuato il 05/09/2025, di 42,5356 azioni a $15.01. La tabella riepiloga le diverse categorie di partecipazione beneficiaria dopo le operazioni riportate, includendo 7.807,5331 azioni detenute indirettamente e altre partecipazioni indirette basate su piani e premi (ad esempio 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Le posizioni in strumenti derivati mostrano opzioni su azioni per un totale di 229,425 opzioni, distribuite in quattro assegnazioni con prezzi di esercizio di $15.60, $15.94, $16.49 e $16.23, con scadenze fino al 2035.

John Klimowich, SEVP y Chief Risk Officer de Columbia Financial, Inc. (CLBK) inform贸 transacciones con fecha 05/09/2025 en un Formulario 4. El reporte muestra una adquisici贸n no derivada el 05/09/2025 de 42.5356 acciones a $15.01. La tabla detalla las distintas categor铆as de propiedad beneficiaria tras las operaciones reportadas, incluyendo 7,807.5331 acciones en posesi贸n indirecta y otras tenencias indirectas basadas en planes y otorgamientos (por ejemplo, 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Las posiciones en derivados muestran opciones sobre acciones por un total de 229,425 opciones repartidas en cuatro concesiones con precios de ejercicio de $15.60, $15.94, $16.49 y $16.23, con vencimientos hasta 2035.

John Klimowich, Columbia Financial, Inc.(CLBK) SEVP 瓴� 斓滉碃鞙勴棙甏�毽眳鞛勳瀽臧� 2025-09-05鞛� 瓯半灅毳� Form 4鞐� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 2025-09-05鞐� 牍勴寣靸� 氚╈嫕鞙茧 42.5356欤茧ゼ 欤茧嫻 $15.01鞐� 旆摑頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 響滌棎電� 鞁犼碃霅� 瓯半灅 鞚错泟鞚� 雼れ枒頃� 鞁れ唽鞙犼秾 氩旍＜臧� 鞝曤Μ霅橃柎 鞛堨溂氅�, 攴胳 臧勳爲 氤挫湢 欤检嫕 7,807.5331欤检檧 頂岆灉 旮半皹 氚� 靾橃棳 旮半皹鞚� 旮绊儉 臧勳爲 氤挫湢(鞓�: 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723)臧� 韽暔霅╇媹雼�. 韺岇儩靸來拡 氤挫湢電� 齑� 229,425欤检潣 鞀ろ啞鞓奠厴鞙茧 雮橅儉雮橂┌, 雱� 瓯挫潣 鞓奠厴 攵�鞐棎 雽�頃� 頄夓偓臧� $15.60, $15.94, $16.49, $16.23鞚搓碃 毵岅赴電� 2035雲勱箤歆�鞛呺媹雼�.

John Klimowich, SEVP et Chief Risk Officer de Columbia Financial, Inc. (CLBK), a d茅clar茅 des transactions dat茅es du 05/09/2025 dans un formulaire 4. Le d茅p么t indique une acquisition non d茅riv茅e le 05/09/2025 de 42.5356 actions au prix de $15.01. Le tableau r茅capitule les diff茅rentes cat茅gories de d茅tention b茅n茅ficiaire apr猫s les transactions d茅clar茅es, incluant 7,807.5331 actions d茅tenues indirectement et d'autres participations indirectes li茅es 脿 des plans et attributions (par exemple 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Les positions en d茅riv茅s montrent des options sur actions totalisant 229,425 options r茅parties sur quatre attributions, avec des prix d'exercice de $15.60, $15.94, $16.49 et $16.23, expirant jusqu'en 2035.

John Klimowich, SEVP und Chief Risk Officer von Columbia Financial, Inc. (CLBK), meldete Transaktionen vom 05.09.2025 in einem Formular 4. Die Einreichung zeigt eine nicht-derivative Erwerbung am 05.09.2025 von 42.5356 Aktien zum Preis von $15.01. Die Tabelle listet die verschiedenen Kategorien der wirtschaftlichen Beteiligung nach den gemeldeten Transaktionen auf, darunter 7.807.5331 Aktien, die indirekt gehalten werden, sowie weitere indirekte Best盲nde aus Pl盲nen und Zuteilungen (z. B. 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Die Derivatpositionen umfassen insgesamt 229,425 Aktienoptionen, verteilt auf vier Optionszuteilungen mit Aus眉bungspreisen von $15.60, $15.94, $16.49 und $16.23 sowie Laufzeiten bis 2035.

Positive
  • Detailed disclosure of indirect holdings across multiple plans and award tranches provides transparency
  • Clear vesting and settlement explanations for awards and options are included in the explanatory remarks
  • Derivative positions disclosed with exercise prices and expiration dates (2029鈥�2035)
Negative
  • Form shows a disposal entry of 60,769 shares (marked 'D') without contextual explanation in the body of the Form
  • Some numeric entries include fractional formats (e.g., 7,807.5331, 42.5356) that may require reconciliation with broker/share records

Insights

TL;DR: Insider acquired a small number of shares and continues to hold substantial option positions and multiple plan-based indirect holdings.

The Form 4 documents a purchase of 42.5356 shares at $15.01 on 09/05/2025 and enumerates numerous indirect holdings tied to retirement, deferral and award plans. The filing also discloses four series of outstanding stock options totaling 229,425 options with exercise prices from $15.60 to $16.49 and expirations ranging from 2029 to 2035. All statements derive directly from the Form 4; the filing includes explanatory notes about plan settlement and vesting schedules for awards and options.

TL;DR: Disclosure is consistent with a director/officer reporting routine equity awards and plan-based holdings, with clear vesting and settlement notes.

The Form 4 identifies the reporting person as SEVP & Chief Risk Officer and provides detail on indirect beneficial ownership via a rabbi trust, 401(k), ESOP, SERP, SIM and multiple stock award tranches. Vesting schedules and settlement mechanics for awards and options are explicitly described in the filing's explanatory remarks. The signature block shows the form was signed by a holder of power of attorney on 09/09/2025.

John Klimowich, SEVP e Chief Risk Officer di Columbia Financial, Inc. (CLBK) ha dichiarato operazioni datate 05/09/2025 in un Modulo 4. La comunicazione indica un acquisto non derivato, effettuato il 05/09/2025, di 42,5356 azioni a $15.01. La tabella riepiloga le diverse categorie di partecipazione beneficiaria dopo le operazioni riportate, includendo 7.807,5331 azioni detenute indirettamente e altre partecipazioni indirette basate su piani e premi (ad esempio 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Le posizioni in strumenti derivati mostrano opzioni su azioni per un totale di 229,425 opzioni, distribuite in quattro assegnazioni con prezzi di esercizio di $15.60, $15.94, $16.49 e $16.23, con scadenze fino al 2035.

John Klimowich, SEVP y Chief Risk Officer de Columbia Financial, Inc. (CLBK) inform贸 transacciones con fecha 05/09/2025 en un Formulario 4. El reporte muestra una adquisici贸n no derivada el 05/09/2025 de 42.5356 acciones a $15.01. La tabla detalla las distintas categor铆as de propiedad beneficiaria tras las operaciones reportadas, incluyendo 7,807.5331 acciones en posesi贸n indirecta y otras tenencias indirectas basadas en planes y otorgamientos (por ejemplo, 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Las posiciones en derivados muestran opciones sobre acciones por un total de 229,425 opciones repartidas en cuatro concesiones con precios de ejercicio de $15.60, $15.94, $16.49 y $16.23, con vencimientos hasta 2035.

John Klimowich, Columbia Financial, Inc.(CLBK) SEVP 瓴� 斓滉碃鞙勴棙甏�毽眳鞛勳瀽臧� 2025-09-05鞛� 瓯半灅毳� Form 4鞐� 鞁犼碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 2025-09-05鞐� 牍勴寣靸� 氚╈嫕鞙茧 42.5356欤茧ゼ 欤茧嫻 $15.01鞐� 旆摑頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 響滌棎電� 鞁犼碃霅� 瓯半灅 鞚错泟鞚� 雼れ枒頃� 鞁れ唽鞙犼秾 氩旍＜臧� 鞝曤Μ霅橃柎 鞛堨溂氅�, 攴胳 臧勳爲 氤挫湢 欤检嫕 7,807.5331欤检檧 頂岆灉 旮半皹 氚� 靾橃棳 旮半皹鞚� 旮绊儉 臧勳爲 氤挫湢(鞓�: 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723)臧� 韽暔霅╇媹雼�. 韺岇儩靸來拡 氤挫湢電� 齑� 229,425欤检潣 鞀ろ啞鞓奠厴鞙茧 雮橅儉雮橂┌, 雱� 瓯挫潣 鞓奠厴 攵�鞐棎 雽�頃� 頄夓偓臧� $15.60, $15.94, $16.49, $16.23鞚搓碃 毵岅赴電� 2035雲勱箤歆�鞛呺媹雼�.

John Klimowich, SEVP et Chief Risk Officer de Columbia Financial, Inc. (CLBK), a d茅clar茅 des transactions dat茅es du 05/09/2025 dans un formulaire 4. Le d茅p么t indique une acquisition non d茅riv茅e le 05/09/2025 de 42.5356 actions au prix de $15.01. Le tableau r茅capitule les diff茅rentes cat茅gories de d茅tention b茅n茅ficiaire apr猫s les transactions d茅clar茅es, incluant 7,807.5331 actions d茅tenues indirectement et d'autres participations indirectes li茅es 脿 des plans et attributions (par exemple 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Les positions en d茅riv茅s montrent des options sur actions totalisant 229,425 options r茅parties sur quatre attributions, avec des prix d'exercice de $15.60, $15.94, $16.49 et $16.23, expirant jusqu'en 2035.

John Klimowich, SEVP und Chief Risk Officer von Columbia Financial, Inc. (CLBK), meldete Transaktionen vom 05.09.2025 in einem Formular 4. Die Einreichung zeigt eine nicht-derivative Erwerbung am 05.09.2025 von 42.5356 Aktien zum Preis von $15.01. Die Tabelle listet die verschiedenen Kategorien der wirtschaftlichen Beteiligung nach den gemeldeten Transaktionen auf, darunter 7.807.5331 Aktien, die indirekt gehalten werden, sowie weitere indirekte Best盲nde aus Pl盲nen und Zuteilungen (z. B. 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Die Derivatpositionen umfassen insgesamt 229,425 Aktienoptionen, verteilt auf vier Optionszuteilungen mit Aus眉bungspreisen von $15.60, $15.94, $16.49 und $16.23 sowie Laufzeiten bis 2035.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Klimowich John
(Last) (First) (Middle)
19-01 ROUTE 208 NORTH
(Street)
FAIR LAWN NJ 07410
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Columbia Financial, Inc. [ CLBK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEVP & Chief Risk Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 A 42.5356(1) A $15.01 7,807.5331 I By Stock-Based Deferral Plan
Common Stock 60,769 D
Common Stock 17,130 I By 401(k)
Common Stock 7,620 I By ESOP
Common Stock 7,051 I By SERP
Common Stock 4,214 I By SIM
Common Stock 13,781 I By Stock Award II(2)
Common Stock 12,068 I By Stock Award III(3)
Common Stock 11,723 I By Stock Award IV(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $15.6 07/23/2020(5) 07/23/2029 Common Stock 188,235 188,235 D
Stock Options (right to buy) $15.94 05/01/2024(6) 05/01/2033 Common Stock 12,030 12,030 D
Stock Options (right to buy) $16.49 03/06/2025(7) 03/06/2034 Common Stock 8,850 8,850 D
Stock Options (right to buy) $16.23 03/03/2026(8) 03/03/2035 Common Stock 20,310 20,310 D
Explanation of Responses:
1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on May 1, 2024; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
5. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on May 1, 2024.
7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
Remarks:
/s/ Dennis E. Gibney, Power of Attorney 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transaction did John Klimowich report on Form 4 for CLBK?

The filing reports an acquisition on 09/05/2025 of 42.5356 shares at $15.01 as shown on the Form 4.

How many stock options does the Form 4 show for John Klimowich?

The filing lists four option grants totaling 229,425 options with exercise prices of $15.60, $15.94, $16.49, and $16.23 and expirations from 07/23/2029 to 03/03/2035.

Which plan-based indirect holdings are disclosed on the Form 4?

The Form 4 discloses indirect holdings attributed to a Stock-Based Deferral Plan (rabbi trust), 401(k), ESOP, SERP, SIM, and multiple Stock Award tranches.

Is there any signature or authorization noted on the Form 4?

Yes. The form is signed by /s/ Dennis E. Gibney, Power of Attorney with a signature date of 09/09/2025.

Does the Form 4 explain vesting schedules for awards and options?

Yes. Explanatory notes state vesting schedules and performance conditions for Stock Awards and vesting commencement dates for option grants as provided in the filing.
Stock CLBK logo
Columbia Financ

NASDAQ:CLBK

CLBK Rankings

#2299 Ranked by Market Cap
N/A Ranked by Dividends

CLBK Latest News

Sep 8, 2025
Columbia Financial, Inc. Announces Seventh Stock Repurchase Program
Jul 30, 2025
Columbia Financial, Inc. Announces Financial Results聽for the Second Quarter Ended June 30, 2025
Apr 30, 2025
Columbia Financial, Inc. Announces Financial Results聽for the First Quarter Ended March 31, 2025
Jan 28, 2025
Columbia Financial, Inc. Announces Financial Results聽for the Fourth Quarter and Year Ended December 31, 2024
Dec 5, 2024
Columbia Financial, Inc. Announces Repositioning of Balance Sheet

CLBK Latest SEC Filings

Sep 9, 2025
[Form 4] Columbia Financial, Inc. Insider Trading Activity
Sep 9, 2025
[Form 4] Columbia Financial, Inc. Insider Trading Activity
Sep 9, 2025
[Form 4] Columbia Financial, Inc. Insider Trading Activity
Sep 9, 2025
[Form 4] Columbia Financial, Inc. Insider Trading Activity
Sep 9, 2025
[Form 4] Columbia Financial, Inc. Insider Trading Activity

CLBK Stock Data

1.58B
26.84M
74.42%
13.11%
1.54%
Banks - Regional
Savings Institution, Federally Chartered
United States
FAIR LAWN